Back to Search
KATHERINE FOSTER, PHARMD
PHARMD
Pharmacist
NPI: 1851862023Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery.
PMID 11064206·Int J Pharm·2000
8-other
Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.
PMID 19487463·Mol Cell Biol·2009
7-preclinical
Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
PMID 18641990·Cancer Chemother Pharmacol·2009
8-other
CHI's Eighth Annual World Pharmaceutical Congress. Targeting pain with novel therapeutics: Part 1.
PMID 19629879·IDrugs·2009
7-preclinical
Social evolution of spatial patterns in bacterial biofilms: when conflict drives disorder.
PMID 19456262·Am Nat·2009
8-other
Generalized melanosis caused by an occult melanoma.
PMID 18761543·J Eur Acad Dermatol Venereol·2009
5-case
The evolution of superstitious and superstition-like behaviour.
PMID 18782752·Proc Biol Sci·2009
7-preclinical
High arctic ponds receiving biotransported nutrients from a nearby seabird colony are also subject to potentially toxic loadings of arsenic, cadmium, and zinc.
PMID 19604032·Environ Toxicol Chem·2009
7-preclinical
Methicillin-resistant Staphylococcus aureus: an assessment of environmental contamination in a burn center.
PMID 19643281·Am J Infect Control·2009
8-other
Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.
PMID 19276766·J Trauma·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 SW 10TH AVE
TOPEKA, KS 66604 - Phone
- (785) 354-6090
Quick Facts
- NPI
- 1851862023
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile